Vonoprazan is a medication used to treat conditions related to excess stomach acid, such as gastroesophageal reflux disease (GERD) and peptic ulcers. Like many pharmaceutical products, vonoprazan is subject to quality control and testing to ensure its purity and safety. Impurities in pharmaceuticals can be unwanted substances that may arise during the manufacturing process or storage of the drug. These impurities can affect the drug’s efficacy and safety.

Impurities in pharmaceuticals can take various forms, including related compounds, degradation products, or contaminants from the manufacturing process. The identification and control of these impurities are crucial for ensuring the quality and safety of the medication.

Alentris Research offers an extensive range of Vonoprazan-related impurities standards with certified Certificate of Analysis (CoA) along with all characterization data like HPLC, 1H NMR, 13C NMR, IR, Mass & TGA report. We also provide CMR, DEPT, and detailed structure characterization reports as per requirements. Vonoprazan-related standards are being used by major pharmaceutical companies across the globe for their ANDA/DMF filing.